Coronary Plaque Characterization Assessed by Optical Coherence Tomography and Plasma Trimethylamine-N-oxide Levels in Patients With Coronary Artery Disease-Reference-Cited by-同舟云学术

Coronary Plaque Characterization Assessed by Optical Coherence Tomography and Plasma Trimethylamine-N-oxide Levels in Patients With Coronary Artery Disease

Published:2016-11 Issue:9 Volume:118 Page:1311-1315
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Fu Qiang,Zhao Mingming,Wang Dezhao,Hu Hongyu,Guo Caixia,Chen Wei,Li Qun,Zheng Lemin,Chen Buxing

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. The pathogenesis of coronary artery disease and the acute coronary syndromes;Fuster;N Engl J Med,1992

2. Vulnerable atherosclerotic plaque: a multifocal disease;Casscells;Circulation,2003

3. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound;Jang;J Am Coll Cardiol,2002

4. Clinical imaging with optical coherence tomography;Bouma;Acad Radiol,2002

5. Intracoronary imaging for detecting vulnerable plaque;Fujii;Circ J,2013

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease;Current Problems in Cardiology;2024-09

2. Cardiovascular Stress Biomarkers in Response to Marathon Running in Male Athletes with Various Plasma Trimethylamine N-oxide Levels;2024-02-02

3. Protocatechuic acid alleviates TMAO-aggravated atherosclerosis via mitigating inflammation, regulating lipid metabolism, and reshaping gut microbiota;Food & Function;2024

4. Gut Microbiota and Its Metabolites: The Emerging Bridge Between Coronary Artery Disease and Anxiety and Depression?;aging and disease;2024

5. Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO;CNS & Neurological Disorders - Drug Targets;2024-01